Skip to main content

How can we help you?

  • Deal or case news
  • 08-11-2017

Yesterday night, InflaRx, a German biotech company, successfully priced the initial public offering of its ordinary shares on NASDAQ. Petra Zijp, Antonia Netiv and Paul van der Bijl led the NautaDutilh team that has been advising InflaRx on this IPO, together with Davis Polk (US counsel) and Taylor Wessing (German counsel).

InflaRx raised USD 100 million in the IPO, making this our fifth consecutive Nasdaq IPO for a Dutch company. Our core team consisted of Petra Zijp, Paul van der Bijl, Antonia Netiv, Jules van de Winckel, Esther Schreiber, Joppe Schoute, Kathrin Bungenberg, Pedro Paraguay, Gijs van Nes and Elias Ram.

Cookie notice

We care about your privacy. We only use cookies strictly necessary to ensure the proper functioning of our website. You can find more information on cookies and on how we handle your personal data in our Privacy and Cookie Policy.